Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

DNA-Based Analysis Detects Group A Streptococcus

By LabMedica International staff writers
Posted on 27 Oct 2016
As an exclusively human pathogen, Group A Streptococcus (GAS; Streptococcus pyogenes) is spread in the community through direct human-to-human transmission and GAS can also colonize a healthy host without any apparent clinical signs or symptoms.

In clinical microbiology, standard cultivation methods are considered the ‘gold standard’ for microorganism detection because the phenotypic characterization of clinical isolates is important for determining the treatment directions, but such methods are laborious and time-consuming.

Medical microbiologist at the Tokyo Medical and Dental University (Japan) and their colleagues collected throat swab samples from October 2013 to June 2014 from students and staff from various departments of the university. More...
Two throat swabs were collected from the upper pharyngeal region of each of the 148 volunteers. One swab was dipped into 500 μL of sterile Trypticase soy broth for the culture-dependent study. The other swab was dipped into 600 μL of the sterile bead solution from the PowerSoil DNA isolation kit (MO BIO Laboratories, Carlsbad, CA, USA) and stored.

Two methods, culture dependent and independent, were used to detect GAS in throat swabs from healthy adults. For the culture-dependent method, swabs were streaked onto two types of agar medium and in addition to streaking; each throat swab dipped tryptic soy broth (TSB) and was also added to 1.2 mL of fresh TSB for enrichment. For the culture-independent study DNA extracted from the other was amplified by polymerase chain reaction (PCR) with two GAS-specific primer pairs: one was a newly designed 16S rRNA-specific primer pair, the other a previously described V-Na+-ATPase primer pair. The cloned PCR products were sequenced using M13 primers and the 3130 Genetic Analyzer (Applied Biosystems, Foster City CA, USA).

The scientists found that although only five (3.4%) of the 148 samples were GAS-positive by the culture-dependent method, 146 (98.6%) were positive for the presence of GAS DNA by the culture-independent method. To obtain serotype information by M type protein gene (emm) typing, they performed nested PCR using newly designed emm primers. They detected the four different emm types in 25 (16.9%) samples, and these differed from the common emm types associated with GAS associated diseases in Japan. The different emm types detected in the healthy volunteers indicate that the presence of unique emm types might be associated with GAS carriage.

The authors concluded that culture-independent methods should be considered for profiling GAS in the healthy hosts, with a view to obtaining better understanding of these organisms. The GAS-specific primers (16S rRNA and V-Na+-ATPase) used in this study can be used to estimate the maximum potential GAS carriage in people. These results suggest that not only school-age children, but also healthy adults can serve as GAS carriers. The study was published on October 11, 2016, in the journal BMC Microbiology.

Related Links:
Tokyo Medical and Dental University
MO BIO Laboratories
Applied Biosystems

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.